【24h】

Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR.

机译:使用一步实时RT-PCR对SARS冠状病毒RNA进行病毒载量定量。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first occurred in humans in the People's Republic of China in November 2002 and has subsequently spread worldwide. A novel virus belonging to the Coronaviridae family has been identified as the cause of this pulmonary disease. The severity of the disease combined with its rapid spread requires the development of fast and sensitive diagnostic assays. RESULTS: A real-time quantitative RT-PCR was designed in the nsp11 region of the replicase 1B domain of the SARS-coronavirus (SARS-CoV) genome. To evaluate this quantitative RT-PCR, cRNA standards were constructed by in vitro transcription of SARS-CoV Frankfurt 1 RNA using T7 RNA polymerase, followed by real-time RT-PCR. The assay allowed quantitation over a range of 10(2) to 10(8) RNA copies per reaction. CONCLUSIONS: Extrapolated to clinical samples, this novel assay has a detection range of 10(4) to 10(10) copies of viral genome equivalents per millilitre. In comparison to the current de facto cRNA Artus Biotech standard, the in-house cRNA standard gives a 100-fold higher absolute quantity, suggesting a possible underestimation of the viral load when using the Artus Biotech standard.
机译:简介:严重急性呼吸系统综合症(SARS)是一种新兴的传染病,最早于2002年11月在中国的人类中发生,并随后在全球范围内传播。已经鉴定出一种属于冠状病毒科的新型病毒是造成这种肺部疾病的原因。疾病的严重程度及其迅速传播要求开发快速,灵敏的诊断方法。结果:在SARS冠状病毒(SARS-CoV)基因组的复制酶1B结构域的nsp11区域设计了实时定量RT-PCR。为了评估这种定量RT-PCR,通过使用T7 RNA聚合酶体外转录SARS-CoV Frankfurt 1 RNA来构建cRNA标准,然后进行实时RT-PCR。该测定允许每个反应在10(2)至10(8)个RNA拷贝范围内进行定量。结论:外推到临床样品,这种新的检测方法的检测范围是每毫升病毒基因组当量10(4)到10(10)拷贝。与当前的事实上的cRNA Artus Biotech标准相比,内部cRNA标准的绝对量高100倍,这表明使用Artus Biotech标准时可能会低估病毒载量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号